About Centuple Global Limited
Data last updated:
Centuple Global Limited is a public limited company based in Nashik, Maharashtra, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 27 September 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L46307MH1991PLC326598. Its GSTIN is 27AAACR9558H2ZX (Maharashtra). The company holds 3 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 531099.
The company has an authorised share capital of ₹750 Cr and a paid-up capital of ₹5.47 Cr. It was formerly known as Rubra Medicaments Private Limited. It is led by directors including Shruti Gupta and Gaurav Kaushik.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Office No.306 Shreenath Enclave Sr No.609/1 Part, Plot No. 6 7 8 Shreehari Kute Marg Nr Samdeep Hotel Mumbai Naka Tidke Colony Nashik 422002, Maharashtra, India – 422002.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹573.81 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.5 Cr (net margin 0.3%) and EBITDA of ₹2.28 Cr (EBITDA margin 0.4%). The net worth stands at ₹23.23 Cr (up 4048.2% YoY). Total assets are valued at ₹29.96 Cr (up 5250% YoY).
The company is associated with 1 brand: Rubra Medicaments. As per MCA filings, the company has satisfied charges of ₹78.6 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 109 deals on record (109 market trades); the latest was in September 2026.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rubramed.com.
Company details
Name history
Centuple Global has undergone 2 name changes throughout its history. The company was previously known as Rubra Medicaments Private Limited, and Centuple Global Limited. The current legal name is Centuple Global Limited.
| Company Name | Status |
|---|---|
| Centuple Global Limited | Current |
| Rubra Medicaments Private Limited | Previous |
CIN history
Centuple Global has 6 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L46307MH1991PLC326598, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L46307MH1991PLC326598 | Current |
| L46305MH1991PLC326598 | Previous |
| L74110MH1991PLC326598 | Previous |
| L33100AP1991PLC013266 | Previous |
| L33100AP1991PTC013266 | Previous |
| L74110TG1991PLC013266 | Previous |
| L33100TG1991PLC013266 | Previous |
Contact details
Centuple Global Limited's registered office is in Nashik, Maharashtra.
- Registered AddressOffice No.306 Shreenath Enclave Sr No.609/1 Part, Plot No. 6 7 8 Shreehari Kute Marg Nr Samdeep Hotel Mumbai Naka Tidke Colony Nashik 422002, Maharashtra, India – 422002
- IndustryBusiness Outsourcing, Business & IT Consulting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Centuple Global operates one associated brand: Rubra Medicaments. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products are supplied to wholesalers, pharmacies, and retail markets. | rubramed.com |
Business activity
The main business activity of Centuple Global is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities |
To see the full business activity and turnover split of Centuple Global Limited, buy the company report.
Financials of Centuple Global Limited
FY 2025-26 filings availableCentuple Global Limited reported revenue of ₹573.81 Cr (up 114662% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 574 | 0.50 | 1.13 | 1.16 | 2.01 | 0.49 | 0.99 |
| Revenue growth | - | -55.8% | -2.6% | -42.3% | +310.2% | -50.5% | - |
| EBITDA | 2.28 | 0.06 | 0.03 | (0.08) | (0.03) | 0.01 | 0.02 |
| EBITDA margin | +0.4% | +12.0% | +2.7% | -6.9% | -1.5% | +2.0% | +2.0% |
| Profit before tax | 2.28 | 0.05 | 0.02 | (0.08) | (0.03) | 0.01 | 0.05 |
| Net profit | 1.50 | 0.05 | 0.03 | (0.08) | (0.04) | 0.01 | 0.02 |
| Net profit margin | +0.3% | +10.0% | +2.7% | -6.9% | -2.0% | +2.0% | +2.0% |
| EPS (₹) | 2.76 | 0.05 | 0.06 | (0.14) | (0.07) | 0.01 | 0.06 |
| Balance sheet | |||||||
| Total assets | 29.96 | 0.56 | 0.53 | 0.65 | 0.58 | 0.62 | 0.61 |
| Net worth | 23.23 | 0.56 | 0.53 | 0.51 | 0.59 | 0.62 | 0.62 |
| Total debt | 6.74 | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 |
| Cash & bank | 0.09 | 0.03 | 0.01 | 0.03 | 0.02 | 0.52 | 0.00 |
| Net working capital | 29.95 | 0.57 | 0.46 | 0.59 | 0.58 | 0.60 | 0.60 |
| Cash flow | |||||||
| Cash from operations | (28.01) | 0.19 | 0.00 | 0.01 | (0.50) | 0.52 | 0.12 |
| Cash from investing | 0.18 | (0.18) | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from financing | 27.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.26) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 279 | 174 | 109 | 11.71 | 0.25 | 0.10 | 0.05 |
| Revenue growth (YoY) | -100.0% | - | - | - | - | - | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Total expenses | 0.18 | 280 | 173 | 107 | 11.62 | 0.18 | 0.14 | 0.08 |
| EBITDA | (0.18) | (0.38) | 0.77 | 1.79 | 0.09 | 0.07 | (0.04) | (0.03) |
| EBITDA margin | - | -0.1% | +0.4% | +1.6% | +0.8% | +28.0% | -40.0% | -60.0% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.18) | (0.38) | 0.77 | 1.79 | 0.09 | 0.07 | (0.02) | (0.03) |
| Tax | 0.00 | 0.10 | 0.20 | 0.47 | 0.00 | 0.00 | 0.00 | 0.01 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 279 | 174 | 109 | 11.71 | 0.25 | 0.10 | 0.05 |
| Revenue growth (YoY) | -100.0% | - | - | - | - | - | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Total expenses | 0.18 | 280 | 173 | 107 | 11.62 | 0.18 | 0.14 | 0.08 |
| EBITDA | (0.18) | (0.38) | 0.77 | 1.79 | 0.09 | 0.07 | (0.04) | (0.03) |
| EBITDA margin | - | -0.1% | +0.4% | +1.6% | +0.8% | +28.0% | -40.0% | -60.0% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.18) | (0.38) | 0.77 | 1.79 | 0.09 | 0.07 | (0.02) | (0.03) |
| Tax | 0.00 | 0.10 | 0.20 | 0.47 | 0.00 | 0.00 | 0.00 | 0.01 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 574 | 0.50 | 1.13 | 1.16 | 2.01 | 0.49 | 0.99 |
| Revenue growth | - | -55.8% | -2.6% | -42.3% | +310.2% | -50.5% | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Total expenses | 572 | 0.44 | 1.10 | 1.24 | 2.04 | 0.48 | 0.97 |
| Employee cost | 0.29 | 0.26 | 0.50 | 0.35 | 0.23 | 0.20 | 0.13 |
| EBITDA | 2.28 | 0.06 | 0.03 | (0.08) | (0.03) | 0.01 | 0.02 |
| EBITDA margin | +0.4% | +12.0% | +2.7% | -6.9% | -1.5% | +2.0% | +2.0% |
| Depreciation | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 2.28 | 0.05 | 0.02 | (0.08) | (0.03) | 0.01 | 0.05 |
| Tax | 0.78 | 0.02 | (0.01) | 0.00 | 0.01 | 0.00 | 0.01 |
| Net profit | 1.50 | 0.05 | 0.03 | (0.08) | (0.04) | 0.01 | 0.02 |
| Net profit margin | +0.3% | +10.0% | +2.7% | -6.9% | -2.0% | +2.0% | +2.0% |
| EPS (₹) | 2.76 | 0.05 | 0.06 | (0.14) | (0.07) | 0.01 | 0.06 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 |
| Reserves & surplus | (3.40) | (4.91) | (4.94) | (5.30) | (5.22) | (5.19) | (5.19) |
| Shareholders' funds (net worth) | 23.23 | 0.56 | 0.53 | 0.51 | 0.59 | 0.62 | 0.62 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 6.74 | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 |
| Total debt | 6.74 | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 29.96 | 0.56 | 0.53 | 0.65 | 0.58 | 0.62 | 0.61 |
| Assets | |||||||
| Gross block | 0.02 | 0.00 | 0.07 | 0.06 | 0.02 | 0.02 | 0.02 |
| Net block | 0.02 | 0.00 | 0.07 | 0.06 | 0.02 | 0.02 | 0.02 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 1.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 338 | 0.29 | 0.71 | 0.43 | 0.67 | 0.22 | 0.29 |
| Cash & bank balances | 0.09 | 0.03 | 0.01 | 0.03 | 0.02 | 0.52 | 0.00 |
| Loans & advances | 3.97 | 0.34 | 0.14 | 0.14 | 0.15 | 0.15 | 0.45 |
| Total current assets | 343 | 0.66 | 0.86 | 0.60 | 0.84 | 0.89 | 0.74 |
| Total current liabilities | 313 | 0.09 | 0.40 | 0.01 | 0.26 | 0.29 | 0.14 |
| Net working capital | 29.95 | 0.57 | 0.46 | 0.59 | 0.58 | 0.60 | 0.60 |
| Total assets | 29.96 | 0.56 | 0.53 | 0.65 | 0.58 | 0.62 | 0.61 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.03 | 0.01 | 0.03 | 0.02 | 0.52 | 0.00 | 0.14 |
| Net cash from operating activities | (28.01) | 0.19 | 0.00 | 0.01 | (0.50) | 0.52 | 0.12 |
| Net cash from investing activities | 0.18 | (0.18) | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 |
| Net cash from financing activities | 27.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.26) |
| Net change in cash | 0.06 | 0.01 | (0.02) | 0.01 | (0.50) | 0.52 | (0.14) |
| Closing cash | 0.09 | 0.03 | 0.01 | 0.03 | 0.02 | 0.52 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | - | -55.8% | -2.6% | -42.3% | +310.2% | -50.5% | - |
| EBITDA growth | +3700.0% | +100.0% | +137.5% | -166.7% | -400.0% | -50.0% | - |
| PBT growth | +4460.0% | +150.0% | +9998.0% | -166.7% | - | -80.0% | +9998.0% |
| Net income growth | +2900.0% | +66.7% | +137.5% | -100.0% | -500.0% | -50.0% | - |
| Revenue CAGR (3Y) | +690.9% | -37.1% | +32.1% | +5.4% | +50.5% | -40.3% | +47.3% |
| EBITDA CAGR (3Y) | - | - | +44.2% | - | -46.0% | - | -20.6% |
| Profitability & leverage | |||||||
| Net income margin | +0.3% | +6.0% | +2.7% | -6.9% | -2.0% | +2.0% | +4.0% |
| Return on capital employed | +11.7% | +1.6% | +0.7% | 0.0% | 0.0% | +0.2% | +0.3% |
| Return on net worth | +9.4% | +0.9% | +1.0% | 0.0% | 0.0% | +0.2% | +0.3% |
| Debt / equity | 0.28 | 0.00 | 0.15 | 0.14 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 57,381.00 | 14.29 | 17.38 | 29.00 | 100.50 | 24.50 | 49.50 |
| Inventory turnover | 1,043.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 3.40 | 1.00 | 1.98 | 2.11 | 4.52 | 1.92 | 3.41 |
| EPS (₹) | 2.76 | 0.05 | 0.06 | (0.14) | (0.07) | 0.01 | 0.06 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 3.78 | 1.02 | 0.97 | 0.30 | 0.45 | 0.51 | 0.50 |
To see the full year-wise statements and ratios of Centuple Global Limited, buy the company report.
Board of directors and KMP of Centuple Global Limited
Centuple Global Limited currently reports 4 directors and 1 key managerial person. 31 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shubham Chaudhary Also directs: Check Point FMCG LLP, Elitecon India FMCG Private Limited | Cfo | 17 Sep 2025 | 1 Years 1 Months | Current |
| Shruti Gupta Also directs: Garg Furnace Limited, Anvi Publishing Private Limited, Accretion Nutraveda Limited and 2 more | Director | 04 Apr 2025 | 1 Years 6 Months | Current |
| Gunjan Gangwal Also directs: Hanman Fit Limited | Additional Director | 17 Dec 2025 | 0 Years 10 Months | Current |
| Gaurav Kaushik | Director | 18 Mar 2026 | 0 Years 7 Months | Current |
| Ashish Jain | Director | 18 Mar 2026 | 0 Years 7 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Apr 2006 | 10001359 | Vijaya Bank | ₹30 Lakh | Satisfied | |
| 03 Apr 2006 | 10004394 | Vijaya Bank | ₹7 Lakh | Satisfied | |
| 02 Sep 1994 | 90137638 | Canara Bank | ₹1 Lakh | Satisfied | |
| 26 May 1993 | 90137504 | Andhra Pradesh State Financial Corporation | ₹20.3 Lakh | Satisfied | |
| 26 May 1993 | 90138820 | Andhra Pradesh State Financial Corporation | ₹20.3 Lakh | Satisfied |
To see the full charge records of Centuple Global Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Centuple Global Limited has 109 deals on record (109 market trades); the latest was in September 2026.
Deals on record (5 of 109)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2026 | Market trade | ₹96.3 Lakh | Buyer: Nova Global Opportunities Fund Pcc - Bluestone, Nova Global Opportunities Fund Pcc - Touchstone, Zeal Global Opportunities Fund Seller: Golden Bio Energy Limited , an individual |
| Dec 2025 | Market trade | ₹62.7 Lakh | Buyer: an individual Seller: Multiplier Share and Stock Advisors Private Limited |
| Oct 2025 | Market trade | ₹16.5 Lakh | Seller: Neo Apex Venture LLP |
| Sep 2025 | Market trade | ₹45.5 Lakh | Buyer: an individual Seller: Pace Stock Broking Services Private Limited, Multiplier Share and Stock Advisors Private Limited |
| Sep 2025 | Market trade | ₹11.6 Lakh | Buyer: Multiplier Share and Stock Advisors Private Limited |
To see the full deal history of Centuple Global Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Centuple Global Limited has 2 court cases on record: 2 filed by Centuple Global. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Writ petition | Filed by the company against Secty Commner of Industries Hyd &Others | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against State Level Committee Rep.Scy.Hyd.& 2 Ot | Disposed |
To see the full case history of Centuple Global Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Centuple Global Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Centuple Global has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACR9558H2ZX | Maharashtra | Active | 26 Jul 2017 |
To see the full GST registrations and return filing status of Centuple Global Limited, buy the company report.
Recent activity
Centuple Global Limited has 36 board changes on record since 2008: 8 appointments and 28 cessations. The latest: Ashish Jain was appointed as Director on 18 Mar 2026.
37 earlier events are in the company report.
News
Frequently asked questions
Centuple Global is an active public limited company based in Nashik, Maharashtra, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 27 September 1991 (35+ years old) and is registered under CIN L46307MH1991PLC326598. Listed on BSE: 531099.
Centuple Global reported revenue of ₹573.81 Cr for FY 2025-26 (up 114662% YoY) based on standalone financials.
Centuple Global has 5 current directors and KMP:
- Shruti Gupta - Director
- Gunjan Gangwal - Additional Director
- Gaurav Kaushik - Director
- Ashish Jain - Director
- Shubham Chaudhary - Cfo
The latest financial statements of Centuple Global on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Centuple Global is 27AAACR9558H2ZX, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Centuple Global is L46307MH1991PLC326598. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Centuple Global is a listed company as per MCA records. Its shares are listed on BSE (code: 531099).
Centuple Global has 2 court cases on record: 2 filed by the company.
Centuple Global was incorporated on 27 September 1991, making it 35+ years old. It is registered with the Registrar of Companies, Mumbai.
Centuple Global has 109 deals on record (109 market trades); the latest was in September 2026.